
Christine J. Saoud
Examiner (ID: 334, Phone: (571)272-0891 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 2899, 1801, 1645, 1616, 1647, 1646, 1812 |
| Total Applications | 1554 |
| Issued Applications | 754 |
| Pending Applications | 185 |
| Abandoned Applications | 636 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 903316
[patent_doc_number] => 07335641
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Method for stimulating hair follicle cell proliferation'
[patent_app_type] => utility
[patent_app_number] => 11/479419
[patent_app_country] => US
[patent_app_date] => 2006-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21376
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335641.pdf
[firstpage_image] =>[orig_patent_app_number] => 11479419
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/479419 | Method for stimulating hair follicle cell proliferation | Jun 28, 2006 | Issued |
Array
(
[id] => 4486306
[patent_doc_number] => 07884073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Modified growth hormone'
[patent_app_type] => utility
[patent_app_number] => 11/476173
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 45018
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/884/07884073.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476173 | Modified growth hormone | Jun 25, 2006 | Issued |
Array
(
[id] => 4486306
[patent_doc_number] => 07884073
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-08
[patent_title] => 'Modified growth hormone'
[patent_app_type] => utility
[patent_app_number] => 11/476173
[patent_app_country] => US
[patent_app_date] => 2006-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 45018
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/884/07884073.pdf
[firstpage_image] =>[orig_patent_app_number] => 11476173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/476173 | Modified growth hormone | Jun 25, 2006 | Issued |
Array
(
[id] => 5850613
[patent_doc_number] => 20060233804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'IGF antagonist peptides'
[patent_app_type] => utility
[patent_app_number] => 11/473753
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 32082
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20060233804.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473753
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473753 | Method of inhibiting insulin-like growth factor-1 (IGF-1) by IGF-1-antagonist peptides | Jun 22, 2006 | Issued |
Array
(
[id] => 4500653
[patent_doc_number] => 07919463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-05
[patent_title] => 'Growth-stimulating polypeptides for use in fish and crustaceans'
[patent_app_type] => utility
[patent_app_number] => 11/989088
[patent_app_country] => US
[patent_app_date] => 2006-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 6330
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/919/07919463.pdf
[firstpage_image] =>[orig_patent_app_number] => 11989088
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/989088 | Growth-stimulating polypeptides for use in fish and crustaceans | Jun 22, 2006 | Issued |
Array
(
[id] => 5490020
[patent_doc_number] => 20090291091
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'USE OF THE GLOBULAR DOMAIN OF ACRP30 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND/OR TREATMENT OF THROMBOSIS-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 11/997181
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 27314
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291091.pdf
[firstpage_image] =>[orig_patent_app_number] => 11997181
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/997181 | USE OF THE GLOBULAR DOMAIN OF ACRP30 FOR THE PREPARATION OF A MEDICAMENT FOR THE PREVENTION AND/OR TREATMENT OF THROMBOSIS-RELATED DISEASES | Jun 19, 2006 | Abandoned |
Array
(
[id] => 5688919
[patent_doc_number] => 20060287234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Wound healing'
[patent_app_type] => utility
[patent_app_number] => 11/455017
[patent_app_country] => US
[patent_app_date] => 2006-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19674
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11455017
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/455017 | Wound healing | Jun 15, 2006 | Abandoned |
Array
(
[id] => 5514189
[patent_doc_number] => 20090214495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'VASCULAR ENDOTHELIAL GROWTH FACTOR-D (VEGF)-D AND FUNCTIONALLY FRAGMENTS THEREOF FOR BONE REPAIRING'
[patent_app_type] => utility
[patent_app_number] => 11/993825
[patent_app_country] => US
[patent_app_date] => 2006-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6409
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214495.pdf
[firstpage_image] =>[orig_patent_app_number] => 11993825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/993825 | VASCULAR ENDOTHELIAL GROWTH FACTOR-D (VEGF)-D AND FUNCTIONALLY FRAGMENTS THEREOF FOR BONE REPAIRING | Jun 8, 2006 | Abandoned |
Array
(
[id] => 5237127
[patent_doc_number] => 20070129284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Single-chain insulin'
[patent_app_type] => utility
[patent_app_number] => 11/439897
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15883
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129284.pdf
[firstpage_image] =>[orig_patent_app_number] => 11439897
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/439897 | Single-chain insulin | May 23, 2006 | Abandoned |
Array
(
[id] => 5204477
[patent_doc_number] => 20070025957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-01
[patent_title] => 'Vascular targeting of ocular neovascularization'
[patent_app_type] => utility
[patent_app_number] => 11/414782
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26823
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20070025957.pdf
[firstpage_image] =>[orig_patent_app_number] => 11414782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/414782 | Vascular targeting of ocular neovascularization | Apr 27, 2006 | Abandoned |
Array
(
[id] => 5688321
[patent_doc_number] => 20060286636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'VEGF variants'
[patent_app_type] => utility
[patent_app_number] => 11/414724
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 39640
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286636.pdf
[firstpage_image] =>[orig_patent_app_number] => 11414724
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/414724 | VEGF variants | Apr 27, 2006 | Abandoned |
Array
(
[id] => 4698835
[patent_doc_number] => 20080221019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-11
[patent_title] => 'Treatment of Inclusion Body Myositis'
[patent_app_type] => utility
[patent_app_number] => 11/909787
[patent_app_country] => US
[patent_app_date] => 2006-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4267
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20080221019.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909787
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909787 | Treatment of Inclusion Body Myositis | Apr 23, 2006 | Abandoned |
Array
(
[id] => 5337856
[patent_doc_number] => 20090054320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-26
[patent_title] => 'VESICULINS'
[patent_app_type] => utility
[patent_app_number] => 11/912111
[patent_app_country] => US
[patent_app_date] => 2006-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22473
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20090054320.pdf
[firstpage_image] =>[orig_patent_app_number] => 11912111
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/912111 | VESICULINS | Apr 19, 2006 | Abandoned |
Array
(
[id] => 5515369
[patent_doc_number] => 20090215676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Method of treatment'
[patent_app_type] => utility
[patent_app_number] => 11/918460
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4822
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215676.pdf
[firstpage_image] =>[orig_patent_app_number] => 11918460
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/918460 | Method of treatment | Apr 12, 2006 | Abandoned |
Array
(
[id] => 9762288
[patent_doc_number] => 08846611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-30
[patent_title] => 'Skin conditions using human growth hormone'
[patent_app_type] => utility
[patent_app_number] => 11/279555
[patent_app_country] => US
[patent_app_date] => 2006-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 33
[patent_no_of_words] => 10415
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11279555
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/279555 | Skin conditions using human growth hormone | Apr 11, 2006 | Issued |
Array
(
[id] => 5666993
[patent_doc_number] => 20060172343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Novel VEGF-like factors'
[patent_app_type] => utility
[patent_app_number] => 11/397289
[patent_app_country] => US
[patent_app_date] => 2006-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5365
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172343.pdf
[firstpage_image] =>[orig_patent_app_number] => 11397289
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397289 | Nucleic acid sequences encoding VEGF-like factors and uses thereof | Apr 3, 2006 | Issued |
Array
(
[id] => 5834655
[patent_doc_number] => 20060246486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Human signal peptide-containing proteins'
[patent_app_type] => utility
[patent_app_number] => 11/386937
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44219
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246486.pdf
[firstpage_image] =>[orig_patent_app_number] => 11386937
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/386937 | Human signal peptide-containing proteins | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5643447
[patent_doc_number] => 20060281902
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-14
[patent_title] => 'Human signal peptide-containing proteins'
[patent_app_type] => utility
[patent_app_number] => 11/386836
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44213
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20060281902.pdf
[firstpage_image] =>[orig_patent_app_number] => 11386836
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/386836 | Human signal peptide-containing proteins | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5834652
[patent_doc_number] => 20060246483
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => '337 human secreted proteins'
[patent_app_type] => utility
[patent_app_number] => 11/366486
[patent_app_country] => US
[patent_app_date] => 2006-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 332241
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20060246483.pdf
[firstpage_image] =>[orig_patent_app_number] => 11366486
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/366486 | 337 human secreted proteins | Mar 2, 2006 | Abandoned |
Array
(
[id] => 5057593
[patent_doc_number] => 20070060515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-15
[patent_title] => 'Epithelial cell specific growth factor keratinocyte growth factor (KGF)'
[patent_app_type] => utility
[patent_app_number] => 11/346626
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15387
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20070060515.pdf
[firstpage_image] =>[orig_patent_app_number] => 11346626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/346626 | Epithelial cell specific growth factor keratinocyte growth factor (KGF) | Feb 2, 2006 | Abandoned |